AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia

Journal of Molecular and Cellular Cardiology

Volumn 91, Issue , 2016, Pages 104-113

  Zaha, Vlad G ^a   Qi, Dake ^a,c   Su, Kevin N ^a   Palmeri, Monica ^a,d   Lee, Hui Young ^a,e   Hu, Xiaoyue ^a   Wu, Xiaohong ^a   Shulman, Gerald I ^a   Rabinovitch, Peter S ^b   Russell, Raymond R ^a,f   Young, Lawrence H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d MAINE MEDICAL CENTER   (United States)

^e Gachon University College of Medicine   (South Korea)

^f Cardiovascular Institute   (United States)

Author keywords

AMPK; Ischemia; Mitochondria; Reperfusion; Signal transduction

Indexed keywords

CATALASE; CITRATE SYNTHASE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 2; CARRIER PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART PROTECTION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; C57BL MOUSE; CARDIAC MUSCLE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MITOCHONDRION; METABOLISM; MYOCARDIAL INFARCTION; NECROSIS; PATHOLOGY; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CATALASE; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NECROSIS; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TRANSGENES;

EID: 84953296173     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.12.032     Document Type: Article

References (46)

1. Zaha V.G., Young L.H. AMP-activated protein kinase regulation and biological actions in the heart. Circ. Res. 2012, 111:800-814.
2. Bergeron R., Ren J.M., Cadman K.S., Moore I.K., Perret P., Pypaert M., et al. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab. 2001, 281:E1340-E1346.
3. Zong H., Ren J.M., Young L.H., Pypaert M., Mu J., Birnbaum M.J., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15983-15987.
4. O'Neill H.M., Maarbjerg S.J., Crane J.D., Jeppesen J., Jorgensen S.B., Schertzer J.D., et al. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16092-16097.
5. Russell R.R., Li J., Coven D.L., Pypaert M., Zechner C., Palmeri M., et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 2004, 114:495-503.
6. Xing Y., Musi N., Fujii N., Zou L., Luptak I., Hirshman M.F., et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem. 2003, 278:28372-28377.
7. Taegtmeyer H., Roberts A.F., Raine A.E. Energy metabolism in reperfused heart muscle: metabolic correlates to return of function. J. Am. Coll. Cardiol. 1985, 6:864-870.
8. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem. 1992, 267:8834-8839.
9. Starkov A.A. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann. N. Y. Acad. Sci. 2008, 1147:37-52.
10. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
11. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front. Biosci. 2003, 8:d369-d391.
12. Weston C.R., Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 2007, 19:142-149.
13. He H., Li H.L., Lin A., Gottlieb R.A. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia. Cell Death Differ. 1999, 6:987-991.
14. Kaiser R.A., Liang Q., Bueno O., Huang Y., Lackey T., Klevitsky R., et al. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J Biol Chem. 2005, 280:32602-32608.
15. Wei J., Wang W., Chopra I., Li H.F., Dougherty C.J., Adi J., et al. c-Jun N-terminal kinase (JNK-1) confers protection against brief but not extended ischemia during acute myocardial infarction. J Biol Chem. 2011, 286:13995-14006.
16. Chambers J.W., Pachori A., Howard S., Iqbal S., LoGrasso P.V. Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats. J Biol Chem. 2013, 288:4000-4011.
17. Schulz E., Dopheide J., Schuhmacher S., Thomas S.R., Chen K., Daiber A., et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 2008, 118:1347-1357.
18. Lopaschuk G.D. AMP-activated protein kinase control of energy metabolism in the ischemic heart. Int. J. Obes. 2008, 32(Suppl. 4):S29-S35.
19. Carvajal K., Zarrinpashneh E., Szarszoi O., Joubert F., Athea Y., Mateo P., et al. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2007, 292:H3136-H3147.
20. Kim A.S., Miller E.J., Wright T.M., Li J., Qi D., Atsina K., et al. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 2011, 51:24-32.
21. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
22. Miller E.J., Li J., Leng L., McDonald C., Atsumi T., Bucala R., et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 2008, 451:578-582.
23. Qi D., Hu X., Wu X., Merk M., Leng L., Bucala R., et al. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J. Clin. Invest. 2009, 119:3807-3816.
24. Frezza C., Cipolat S., Scorrano L. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2007, 2:287-295.
25. Rogers G.W., Brand M.D., Petrosyan S., Ashok D., Elorza A.A., Ferrick D.A., et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS ONE 2011, 6.
26. Blattner J.R., He L., Lemasters J.J. Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader. Anal. Biochem. 2001, 295:220-226.
27. Panov A.V., Andreeva L., Greenamyre J.T. Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. Arch. Biochem. Biophys. 2004, 424:44-52.
28. Lee H.Y., Choi C.S., Birkenfeld A.L., Alves T.C., Jornayvaz F.R., Jurczak M.J., et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010, 12:668-674.
29. Trounce I.A., Kim Y.L., Jun A.S., Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 1996, 264:484-509.
30. Jastroch M., Divakaruni A.S., Mookerjee S., Treberg J.R., Brand M.D. Mitochondrial proton and electron leaks. Essays Biochem. 2010, 47:53-67.
31. Theruvath T.P., Snoddy M.C., Zhong Z., Lemasters J.J. Mitochondrial permeability transition in liver ischemia and reperfusion: role of c-Jun N-terminal kinase 2. Transplantation 2008, 85:1500-1504.
32. Athea Y., Viollet B., Mateo P., Rousseau D., Novotova M., Garnier A., et al. AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes 2007, 56:786-794.
33. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol. 1983, 244:H743-H748.
34. Howden R. Nrf2 and cardiovascular defense. Oxidative Med. Cell. Longev. 2013, 2013:104308.
35. Jeon S.M., Chandel N.S., Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012, 485:661-665.
36. Ananthakrishnan R., Kaneko M., Hwang Y.C., Quadri N., Gomez T., Li Q., et al. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol. 2009, 296:H333-H341.
37. Balteau M., Van Steenbergen A., Timmermans A.D., Dessy C., Behets-Wydemans G., Tajeddine N., et al. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. Am J Physiol Heart Circ Physiol. 2014.
38. Liu H., Zhang H., Iles K.E., Rinna A., Merrill G., Yodoi J., et al. The ADP-stimulated NADPH oxidase activates the ASK-1/MKK4/JNK pathway in alveolar macrophages. Free Radic. Res. 2006, 40:865-874.
39. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic. Biol. Med. 2011, 51:1289-1301.
40. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca2+ is dependent on mitochondrial-generated reactive oxygen species. FEBS Letters. 1996, 378:150-152.
41. Wiltshire C., Matsushita M., Tsukada S., Gillespie D.A., May G.H. A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem. J. 2002, 367:577-585.
42. Balaban R.S. The role of Ca(2+) signaling in the coordination of mitochondrial ATP production with cardiac work. Biochim. Biophys. Acta 1787, 2009:1334-1341.
43. Sack M.N. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc. Res. 2006, 72:210-219.
44. Alavian K.N., Li H., Collis L., Bonanni L., Zeng L., Sacchetti S., et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
45. Ma H., Wang J., Thomas D.P., Tong C., Leng L., Wang W., et al. Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation 2010, 122:282-292.
46. Paiva M.A., Rutter-Locher Z., Goncalves L.M., Providencia L.A., Davidson S.M., Yellon D.M., et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2011, 300:H2123-H2134.